Unlock the Future of Unrelated ATMPs – Exclusive Workshop
Join us for an exclusive workshop designed to equip you with the tools needed to request starting materials for allogeneic therapies.
Why Attend?
This workshop is tailored for cell and gene therapy developers, manufacturers, researchers, and transplant physicians seeking to acquire high quality starting materials and donor registries providing these products.
What You Will Learn:
Case studies from leading experts in the field
Practical strategies for integrating allogeneic cell and gene therapy into transplant programs
Event Details
📅 Date: March 30, 2025 from 1:00PM till 5:30PM
📍 Location: Forterza Da Basso Congress Venue, room XXXX
Scientific Programme
1:00 Welcome – Jay Feinberg, president of WMDA
Moving into the world of CAR-T – perspective from Bio-Pharma
1:10 Developing allogeneic, switchable CAR-T cell products – Marc Cartellieri Avencell
1:30 From the view of pharmaceutical versus the view of the donor registries – Carla Kreissig/Jay Feinberg
Moving into the world of CAR-T – perspective from Donor Registries
1:50 What are the differences between standard donor workup for transplant and pharma? – Richaele Nichiporenko Gift of Life
2:10 What differentiates registries from other starting material providers? – TBA
2:30 Panel discussion moderated by Tom Brenner, Amy Ronneberg and speakers
For discussion: Challenges and opportunities, benefits of donors sourced from registries versus commercial providers, meeting both customer and registry needs.
3:00 Closure